# AI Clinical Intelligence Platform

## Product Scope & Non-Goals Specification

**Document:** Product Scope & Non-Goals
**Version:** 1.0
**Status:** Approved for Development
**MVP Boundary:** S4 — Clinical Agent

---

## 1. Product Objective

The AI Clinical Intelligence Platform is a clinical decision-support system designed to help doctors quickly understand what is important about a patient and identify potentially significant findings that may otherwise be overlooked.

The platform combines:

* Patient history
* Current symptoms and encounters
* Laboratory results
* Clinical reports and documents
* Medical knowledge
* AI-powered analysis
* Longitudinal patient trends
* Medical imaging analysis as a future capability

The primary question the system should help answer is:

> **"What is important about this patient right now, and what might I be missing?"**

The platform is intended to **assist clinicians, not replace them**.

The doctor remains responsible for reviewing the available evidence and making the final clinical decision.

---

## 2. Target Users

### Primary User — Doctor / Clinician

Doctors use the platform to:

* Search for authorized patients
* Review patient history
* Review laboratory results
* Review reports and clinical documents
* Understand important changes over time
* Ask clinical questions about the available patient information
* Generate AI-assisted clinical insights
* Review supporting evidence
* Review uncertainty and missing information
* Make the final clinical decision

### Secondary User — Hospital Administrator

Administrators use the platform to:

* Manage users
* Manage roles and permissions
* Configure system-level settings
* Manage approved medical knowledge sources
* Review audit logs
* Monitor system health and usage

Administrative privileges do **not automatically grant unrestricted access to clinical records**.

Clinical data access must follow least-privilege and authorization rules.

---

## 3. MVP Scope

The MVP consists of the following stages:

### S1 — Patient 360

Provide a unified patient view containing:

* Patient demographics
* Current encounter
* Medical history
* Diagnoses recorded in the system
* Medications
* Laboratory results
* Clinical documents
* Relevant reports

### S2 — Lab Intelligence

Analyze laboratory results to identify:

* Abnormal values
* Significant changes from previous results
* Patient-specific baseline deviations
* Persistent abnormal trends
* Potentially important patterns

Deterministic calculations should be performed by application logic where possible rather than relying on an LLM to perform numerical analysis.

### S3 — Clinical RAG

Provide retrieval-augmented generation using approved medical knowledge sources.

The system should:

* Retrieve relevant medical information
* Provide supporting sources
* Distinguish retrieved medical knowledge from patient-specific information
* Avoid unsupported medical claims
* Indicate when relevant evidence cannot be found

### S4 — Clinical Agent

Combine:

* Patient context
* Clinical history
* Symptoms
* Laboratory intelligence
* Clinical documents
* Medical knowledge
* AI reasoning/orchestration

The agent produces a structured clinical-support response for the doctor.

**S4 is the MVP completion boundary.**

---

## 4. Human-in-the-Loop Requirement

The platform is a **clinical decision-support system**.

It must not autonomously make or execute medical decisions.

The AI must:

* Present its findings as decision support
* Provide supporting evidence
* Communicate uncertainty
* Identify missing information
* Clearly distinguish facts from interpretation
* Allow the doctor to review the information before acting

The doctor remains the final decision-maker.

The system must never imply that an AI-generated suggestion is a confirmed diagnosis or treatment decision.

---

## 5. AI Output Boundaries

AI-generated responses must follow these principles:

### Evidence First

Important claims should be supported by:

* Patient records
* Laboratory results
* Clinical documents
* Medical knowledge sources
* Imaging model outputs when imaging functionality is introduced

### No Unsupported Claims

If sufficient evidence is unavailable, the system should explicitly state that there is insufficient evidence.

### Uncertainty

The system should communicate uncertainty when:

* Evidence is incomplete
* Multiple interpretations are possible
* Data quality is poor
* Required information is missing
* The AI cannot confidently support a conclusion

### Facts vs Interpretation

The system should clearly distinguish:

**Patient facts**

Example:

> Hemoglobin decreased from 13.4 g/dL to 10.8 g/dL.

from:

**Clinical interpretation**

Example:

> This change may warrant further clinical evaluation depending on the patient's overall context.

### No Definitive Autonomous Diagnosis

The platform may surface:

* Potential clinical considerations
* Possible patterns
* Relevant abnormalities
* Potential red flags
* Questions the clinician may wish to investigate

It must not present these as definitive autonomous diagnoses.

---

## 6. Structured AI Response

The preferred AI response structure is:

```text
Patient Summary
Significant Changes
Clinical Considerations
Red Flags
Missing Information
Evidence
Uncertainty
Safety Status
```

The system should support a machine-readable representation containing equivalent fields:

* `patientSummary`
* `significantChanges`
* `clinicalConsiderations`
* `redFlags`
* `missingInformation`
* `evidence`
* `uncertainty`
* `safetyStatus`

Possible safety statuses:

* `PASS`
* `REVIEW_REQUIRED`
* `INSUFFICIENT_EVIDENCE`

---

## 7. Data Requirements

During development, the project must use only:

* Synthetic data
* De-identified data
* Public datasets that explicitly permit the intended use

Real patient-identifiable health information must not be used in the development environment unless appropriate legal, organizational, security, and compliance requirements have been established.

Development datasets should be designed to represent realistic clinical scenarios without exposing real patient identities.

---

## 8. Privacy & Security Requirements

The platform must be designed with production healthcare security requirements in mind.

Core requirements include:

* Authentication
* Role-based access control
* Resource-level authorization
* Least-privilege access
* Audit logging
* Encryption in transit
* Encryption at rest where applicable
* No sensitive patient information in application logs
* Secure service-to-service communication
* Deny-by-default authorization
* Controlled access to clinical data

Every access to sensitive patient information should be auditable.

---

## 9. Evidence & Traceability

AI-generated clinical insights must be traceable to their supporting information.

The platform should allow the doctor to understand:

> **"Why did the system say this?"**

Evidence may include:

* Patient record identifiers
* Laboratory result identifiers
* Document references
* Relevant report sections
* Medical knowledge sources
* Imaging model findings

The system should avoid producing conclusions that cannot be traced back to available evidence.

---

## 10. Medical Imaging Boundary

Medical imaging is an important future capability but is **not required for the initial MVP**.

Future imaging functionality may include:

* X-ray analysis
* CT analysis
* MRI analysis
* Other medical imaging modalities

Generic LLMs should not be treated as the primary medical image-detection system.

Instead, imaging should use specialized medical imaging/computer-vision models appropriate for the specific modality and task.

Imaging capabilities should be introduced incrementally, beginning with a narrowly defined and properly evaluated use case.

---

## 11. Non-Goals

The following are explicitly outside the initial MVP scope.

### Autonomous Diagnosis

The platform will not independently diagnose patients.

### Autonomous Treatment

The platform will not independently prescribe, modify, or execute treatment.

### Autonomous Clinical Actions

The AI will not independently:

* Order tests
* Prescribe medication
* Change medication
* Schedule procedures
* Contact patients
* Execute clinical workflows

### General-Purpose Medical Chatbot

The platform is not intended to be a generic medical chatbot for unrestricted public use.

Its primary purpose is **patient-context-aware clinical decision support for authorized clinicians**.

### Full Medical Imaging Platform

Advanced multi-modality imaging analysis is not part of the initial MVP.

### Hospital Production Integration

Integration with real hospital EHR/EMR systems is not required for the initial MVP.

Integration can be addressed after the core system has been evaluated.

### Clinical Effectiveness Claims

The project must not claim that it improves patient outcomes or clinical decision-making until appropriate formal evaluation has been performed.

---

## 12. MVP Success Criteria

The MVP should demonstrate that the platform can:

1. Retrieve the correct authorized patient context.
2. Present a useful Patient 360 view.
3. Detect meaningful laboratory abnormalities and trends.
4. Retrieve relevant medical knowledge.
5. Generate evidence-backed clinical considerations.
6. Clearly distinguish patient facts from AI interpretation.
7. Identify uncertainty and missing information.
8. Provide traceable supporting evidence.
9. Respect authorization boundaries.
10. Maintain an auditable record of sensitive actions.
11. Fail safely when evidence is insufficient.

These criteria demonstrate technical and clinical-support usefulness.

They do not constitute evidence of clinical effectiveness or medical safety in real-world patient care.

---

## 13. MVP Completion Boundary

The initial MVP is considered complete when **S4 — Clinical Agent** has been implemented and satisfies the defined security, evidence, safety, and evaluation requirements.

The following stages are considered future expansion:

* S5 — Imaging MVP
* S6 — Longitudinal Imaging
* S7 — Evaluation & Safety expansion
* S8 — Hospital Integration

---

## 14. Core Product Principle

The platform should follow one central principle:

> **AI should help the doctor see more, understand faster, and miss less — while the doctor remains in control.**

---

## 15. S0-T01 Acceptance Criteria

S0-T01 is complete when the following are explicitly documented:

* Product objective
* Target users
* MVP scope
* Non-goals
* Human-in-the-loop requirements
* AI output boundaries
* Data requirements
* Privacy requirements
* Evidence and traceability requirements
* Medical imaging boundaries
* MVP completion boundary

**Status: DONE**
